News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Non-alcoholic fatty liver disease is very common, in which subgroup does cancer develop more frequently – Osman Sütcüoğlu
Photo of Osman Sütcüoğlu from kirsehireah.saglik.gov.tr
Jul 8, 2023, 11:30

Non-alcoholic fatty liver disease is very common, in which subgroup does cancer develop more frequently – Osman Sütcüoğlu

Non-alcoholic fatty liver disease is very common, in which subgroup does cancer develop more frequently?  

The incidence of HCC development is increasing in patients with type 2 diabetes.

A must-read article! – Click here

Source: Osman Sütcüoğlu/Twitter

cancer Non-alcoholic fatty liver OncoDaily Oncology Osman Sütcüoğlu type 2 diabetes
Special Coverage
Insight
May 10, 2025, 16:12
Patrick Hwu highlights 2025 study by Jonathan Zager on Melphalan hepatic perfusion for metastatic uveal melanoma
Celebrities
May 10, 2025, 16:06
In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection
Blog
May 10, 2025, 16:04
Ruben Mesa Shares Personal Skin Cancer Experience to Raise Awareness
Career
May 10, 2025, 15:50
Bill Gates: The Last Chapter of My Career
Opinion
May 10, 2025, 15:49
Tanja Obradovic Highlights FDA's input and critical role in advancing cell therapy field
Blog
May 10, 2025, 15:35
Gregg Margolis: Three Things to Read About Health Policy This Week
Blog
May 10, 2025, 15:18
Amanda Nasrallah: Thrilled to share my latest publication in the journal of Medicine Care and Health review
Positive
May 10, 2025, 15:17
Patrick Hwu: Productive and Informative Meeting of The Florida Council of 100
Blog
May 10, 2025, 15:01
SIOP Africa 2026 Congress is just 342 days away - The Dorcas Cancer Foundation
Blog
May 10, 2025, 15:01
Susanna Fletcher Greer: Thrilled to Partner with the Cancer Vaccine Coalition
Blog
May 10, 2025, 14:36
Abdulla Alzibdeh: Tumor-Directed SBRT May Enhance Outcomes in LA-NSCLC on Durvalumab
Blog
May 10, 2025, 14:23
GEC-ESTRO Urology: Hathal Haddad Highlights Updates on Urological Cancer Brachytherapy